Sepsis redefined: the search for surrogate markers

International Journal of Antimicrobial Agents
Ephraim L Tsalik, Christopher W Woods

Abstract

Sepsis is a common and severe medical condition with substantial associated morbidity, mortality and cost. Furthermore, the incidence of sepsis has been rising annually over the past three decades, and morbidity and mortality remain high. The management of sepsis is further complicated by its very heterogeneous nature. This extends not only to the offending pathogens, but also to the nature and severity of the host response as well as its clinical manifestations. Efforts to identify surrogate markers for sepsis have therefore been an ongoing struggle. In this article we present some insights into various sepsis markers through history, presenting advantages and caveats associated with their use and interpretation. We also discuss the state of functional genomics, a relatively recent technological advancement that has already begun to change our understanding of sepsis pathophysiology, and offer new directions in the development of a more sensitive and specific sepsis biomarker.

References

Oct 1, 1975·American Journal of Diseases of Children·M Weitzman
Oct 1, 1985·Critical Care Medicine·W A KnausJ E Zimmerman
Oct 1, 1983·The Journal of Experimental Medicine·B PerussiaG Trinchieri
Aug 1, 1997·Critical Care Medicine·E S NylénA Alzeer
Mar 7, 2001·The Journal of Clinical Endocrinology and Metabolism·B MüllerJ F Habener
Mar 10, 2001·The New England Journal of Medicine·G R BernardUNKNOWN Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group
Jul 11, 2001·Critical Care Medicine·D C Angus, R S Wax
Jan 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Gerard J NauRichard A Young
Sep 11, 2002·Cytokine & Growth Factor Reviews·Katsuhiko Ishihara, Toshio Hirano
Nov 15, 2002·Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology·Esther Layseca-EspinosaRoberto González-Amaro
Apr 18, 2003·The New England Journal of Medicine·Greg S MartinMarc Moss
Mar 18, 2004·Critical Care : the Official Journal of the Critical Care Forum·Gary T KinasewitzUNKNOWN PROWESS Sepsis Study Group
Jul 22, 2005·Genes and Immunity·D C ThachUNKNOWN Epidemic Outbreak Surveillance (EOS)
Sep 2, 2005·Nature·Steve E CalvanoUNKNOWN Inflamm and Host Response to Injury Large Scale Collab. Res. Program
Oct 26, 2005·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Emanuel P RiversKandis K Rivers
Apr 26, 2006·Critical Care : the Official Journal of the Critical Care Forum·Pedro PóvoaHenrique Sabino
May 11, 2006·Archives of Pathology & Laboratory Medicine·Bruce H DavisNancy C Bigelow
Mar 14, 2008·Current Medicinal Chemistry·I Herzum, H Renz
Dec 6, 2008·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Paddy McMasterJohn Belcher
Feb 10, 2009·Annals of Emergency Medicine·James D ChalmersAdam T Hill
Mar 18, 2009·Critical Care : the Official Journal of the Critical Care Forum·Pierre Emmanuel CharlesJean Pierre Quenot
Apr 30, 2009·Anaesthesia and Intensive Care·K M Ho, J Lipman

❮ Previous
Next ❯

Citations

Jan 3, 2012·International Journal of Biological Sciences·Yaozong ZhangLin Chen
Jul 7, 2015·Expert Review of Molecular Diagnostics·Emily R KoEphraim L Tsalik
Nov 8, 2011·The Journal of Emergency Medicine·Ephraim L TsalikChristopher W Woods
Sep 10, 2014·Trends in Molecular Medicine·Aimee K ZaasGeoffrey S Ginsburg

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.